Skip to main content

Systematic approach to contextualize findings of flexible endoscopic evaluation of swallowing in neurogenic dysphagia– towards an integrated FEES report

Abstract

Flexible endoscopic evaluation of swallowing (FEES) is one of the most important methods for instrumental swallowing evaluation. The most challenging part of the examination consists in the interpretation of the various observations encountered during endoscopy and in the deduction of clinical consequences. This review proposes the framework for an integrated FEES-report that systematically moves from salient findings of FEES to more advanced domains such as dysphagia severity, phenotypes of swallowing impairment and pathomechanisms. Validated scales and scores are used to enhance the diagnostic yield. In the concluding part of the report, FEES-findings are put into the perspective of the clinical context. The potential etiology of dysphagia and conceivable differential diagnoses are considered, further diagnostic steps are proposed, treatment options are evaluated, and a timeframe for re-assessment is suggested. This framework is designed to be adaptable and open to continuous evolution. Additional items, such as novel FEES protocols, pathophysiological observations, advancements in disease-related knowledge, and new treatment options, can be easily incorporated. Moreover, there is potential for customizing this approach to report on FEES in structural dysphagia.

Introduction

Flexible Endoscopic Evaluation of Swallowing (FEES) was first described in 1988 by the American speech and language pathologist (SLP) Susan Langmore and defined as a procedure separate from conventional otorhinolaryngoscopy, which lacks evaluation of swallowing [1]. Since then, FEES has been taken up by clinicians all around the world. Thus, FEES is regularly performed by SLPs and different medical professions, in particular neurologists, phoniatricians, otolaryngologists, geriatricians, pediatricians and intensivists, and is used in a variety of settings, such as outpatient care, acute-care hospitals, including stroke units and intensive care units, rehabilitation facilities and nursing homes [2,3,4]. Over the last years, education in FEES has undergone systematic formalization in various countries, including the United States [5], Great Britain [6], Germany [3, 7] and Japan [8]. Notably, the European Society for Swallowing Disorders (ESSD) has developed a transnational and multidisciplinary education program [9]. Therefore, along with the Videofluoroscopic Swallowing Study (VFSS), FEES today is the most commonly adopted method for instrumental dysphagia evaluation [2]. In terms of day-to-day practicality, FEES offers several advantages: First, it can be conducted at the bedside, allowing examination of severely motor-impaired, bedridden, or uncooperative patients—common scenarios in settings like the intensive care unit or stroke unit. Second, follow-up examinations can be promptly and, if necessary, frequently performed. Third, the assessment of oropharyngeal secretion management and the efficacy of cleaning mechanisms, such as coughing and throat clearing, can be conducted simply and directly. Lastly, therapeutic maneuvers can be implemented and assessed with immediate visual feedback for the care-giver and patient.

Due to these benefits, FEES holds a pivotal position in the diagnostic algorithm for neurogenic dysphagia, which offers a structured approach to effectively manage this challenging condition (Fig. 1) [10].

Fig. 1
figure 1

Structured algorithm for the diagnosis of neurogenic dysphagia [10] (FEES = Flexible Endoscopic Evaluation of Swallowing; VFSS = Videofluoroscopic Swallowing Study)

The endoscopic swallowing evaluation typically follows the FEES standard protocol, which may be adapted and expanded based on specific protocols tailored to particular tasks or clinical questions [2].

The final and intellectually most challenging part of the examination involves the multi-level interpretation of the diverse observations encountered during endoscopy and the deduction of clinical consequences. This review aims to provide guidance to meet this challenge by summarizing the necessary steps to systematically move from the salient findings to individualized diagnostic and therapeutic recommendations, thereby creating the framework of an integrated FEES report.

Basic assessment

As shown in Fig. 2, the first part of the integrated report focuses on the identification and grading of the key findings of the endoscopic swallowing assessment and is designed as a five-step approach.

Fig. 2
figure 2

Framework of the integrated FEES report (Medicalgraphics.de; Cologne, Germany)

(AD = Alzheimer‘s Dementia, BRACS = Boston Residue and Clearance Scale, DIGEST = Dynamic Grading of Swallowing Toxicity, DISH = Diffuse idiopathic skeletal hyperostosis, EMG = Electromyography, FTD = Frontotemporal Dementia, GBS = Gullain-Barré Syndrome, HRM = High Resolution Manometry, LEMS = Lambert-Eaton Myathenic Syndrome, MRI = Magnetic Resonance Imaging, MSA = Multiple System Atrophy, NCS = Nerve Conduction Study, PAS = Penetration Aspiration Scale, PNS = Peripheral Nervous System, PSP = Progressive Supranucelar Palsy, SBMA = Spinobulbar muscular atrophy, SSRS = Secretion Severity Rating Scale, VD = Vascular Dementia, VFSS = Videofluoroscopic Swallowing Study, YPRSRS = Yale Pharyngeal Residue Severity Scale)

Step 1– Clinical context and risk profile

As prelude to FEES, the key elements of the clinical context at hand should be noted systematically. The first category assesses the focus of the examination. In the scenario of an already established dysphagia, FEES is usually carried out to plan further treatment or monitor the course of the disease. Patients with subjective swallowing complaints but no previous instrumental assessment are studied to objectively evaluate the swallowing function. Finally, in patients with a tracheal cannula or directly post-extubation the issue of airway safety is often in the focus of FEES. The second important differentiation refers to the time course of the illness. On the one hand the patient may be acutely ill, either due to the onset of a new disease, such as stroke, or due to the acute worsening of a chronic condition, such myasthenia gravis or Parkinson’s disease (i.e. myasthenic or akinetic crisis). On the other hand, FEES may take part in a stable medical condition, for example within a long-term scheduled outpatient counseling due to a slowly progressive swallowing impairment. The third dimension targets dysphagia-related complications and other clues from the patient’s history suggesting a relevant and short-term decline in swallowing function. To this end, it should be noted whether the patient has recently suffered episodes of aspiration pneumonia, experienced an unwanted weight-loss or reports other critical issues like change of diet and frequent coughing during mealtimes [10]. This principled distinction between a high-risk and a low-risk scenario is important since it impacts on the treatment strategies determined further down the line. In acute stroke, for example, aspiration observed during FEES substantially increases the short-term risk of aspiration pneumonia and therefore necessitates a very cautious feeding strategy often implementing temporary tube feeding [11, 12]. At the other end of the spectrum dysphagia with aspiration, which is detected in up to 20% of early-stage Parkinson’s disease [13] and 30% of patients with inflammatory myopathies [14], will be handled much less rigorously in these conditions, in particular if there is no indication of recent dysphagia-related complications.

Step 2– The salient findings

According to Langmore the so called salient findings of FEES consist of premature spillage, delayed swallowing reflex, residue, penetration and aspiration [15, 16]. Salient findings should be described separately for all tested consistencies. In addition, a grading of severity should be provided. For rating of penetration and aspiration of bolus material the penetration-aspiration scale (PAS) may be used [17]. In order to semiquantitatively score penetration/aspiration of saliva the secretion severity rating scale (SSRS) may be applied [18]. Both the PAS and the SSRS have been shown to be valid and reliable [19,20,21]. Suggested scales for residue rating include the Yale Pharyngeal Residue Severity Rating Scale (YPRSRS) [22] and the Boston Residue And Clearance Scale (BRACS) [23]. Both scales have shown excellent reliability and validity, while up to now the YPRSRS seems to have achieved a more profound dissemination in the scientific community. Thus, the YPRSRS has been translated into a variety of different languages [24,25,26], has received independent testing for reliability and validity [27] and has been used in a high number of clinical trials [28,29,30,31,32,33]. Contrasting with this the BRACS, which is somewhat more complicated to score, has so far been only adopted in one study on dysphagia in Parkinson’s disease [34]. Semiquantitative assessment of premature spillage and delayed or absent swallowing reflex may be based on comparatively simple scores that have been shown reasonable interrater reliability. Thus, for characterizing premature spillage a 5-point scale was developed (0 = bolus is behind the tongue, 1 = bolus is at the base of the tongue or valleculae, 2 = the bolus moves to lateral channels or the tip of the epiglottis, 3 = the bolus is in the piriforms or touches the laryngeal rim, 4 = the bolus falls into the laryngeal vestibule) [35,36,37]. The timing of the swallowing reflex may be broken down into 0 = normal reflex latency, 1 = delay of swallowing reflex ≥ 3 s after the bolus has reached the valleculae, 2 = no swallowing reflex is elicited [37].

Step 3– Swallowing safety and swallowing efficiency

Swallowing safety denotes the patient’s ability to protect the airway by a timely laryngeal vestibule closure [38]. Clinical correlates of impaired swallowing safety are cough, voice change, bolus aspiration with immediate respiratory distress and aspiration pneumonia. For assessing swallowing safety, the PAS score determined in step 1 is used. Swallowing efficiency refers to the ability to transport food and liquid through the oral cavity and the pharynx into the esophagus without post-swallow residues [38]. Bolus transfer through the alimentary tract is related to adequate pressure generation behind the bolus to allow sufficient propulsive force [39]. Patients with impaired swallowing efficiency may typically report the feeling of food getting stuck in the throat, the necessity to chew more carefully and to have repetitive clearing swallows and longer duration of mealtimes. Weight loss and malnutrition are the key complications of this impairment. For assessing swallowing efficiency, a residue scale, preferentially the YPRSRS, should be used. As conclusion of step 2 the main problem of the patient’s swallow within these coordinates should be noted. Thus, there may be (i) a single issue with either swallowing safety or efficiency, (ii) both domains may be impaired unrelated from each other, or (iii) swallowing safety maybe impaired because of critically reduced swallowing efficiency.

Step 4– Dysphagia severity

As fourth step of the basic assessment a global rating of the observed swallowing impairment should be provided. This rating constitutes a summary observation, which helps, among others, to precisely and comprehensibly inform other health care professionals involved in the treatment of the patient of the severity of dysphagia and of potential changes over time. To date, the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST), which has originally been conceived and refined for the rating of VFSS [40, 41], may be considered as an appropriate measures for this purpose. In the meantime, the DIGEST-FEES has been successfully validated by two independent groups [42, 43]. While this score has been developed for assessing dysphagia in head and neck cancer patients, it seems likely that it will be rapidly applied to other clinical contexts and patient populations. Thus, recently, the DIGEST-FEES has been successfully used to track the effectiveness of swallowing therapy in a cohort of chronic stroke victims [44] and has also been evaluated for potential use in patients with Parkinson’s disease [45]. In brief, the DIGEST-FEES is a five-point ordinal score that rates dysphagia at the patient level rather than on the bolus level and considers the two dimensions of swallowing safety and swallowing efficiency. The two-way interaction of swallowing safety and swallowing efficiency results in the DIGEST score, which classifies swallowing impairment into none (score 0), mild (score 1), moderate (score 2), severe (score 3) and life-threatening (score 4) [42].

As a somewhat less complex alternative the FEES dysphagia score may be used, which grades dysphagia on a 4-point scale into 0 = none, 1 = mild (premature spillage and/or residue but no penetration/aspiration), 2 = moderate (penetration/aspiration of one consistency) and 3 = severe (penetration/aspiration of two or more consistencies) [36]. This score has been adopted in different patient cohorts such as Parkinson’s disease [35], progressive supranuclear palsy [36], essential tremor [46], myasthenia gravis [47] and Guillain-Barré syndrome [48]. In addition, the multicenter prospective FEES-registry study showed that the FEES dysphagia score was highly correlated with the Functional Oral Intake Scale (FOIS) with scores of 0 and 1 being related to full oral intake levels with some degree of preparation and/or compensation, score of 2 being matched with FOIS level 4 indicating full oral nutrition with one consistency, and score of 3 requiring tube feeding with inconsistent oral intake [49]. In addition, there are scores for grading dysphagia in specific diagnostic groups, such as the fiberoptic endoscopic dysphagia severity scale (FEDSS) for acute stroke patients or the FEES-L-Dopa test for patients with Parkinsonian syndromes [36, 50].

Step 5– Effect of swallowing interventions

A key advantage of FEES consists in the possibility of immediately testing swallowing maneuvers, head postures and bolus modifications to improve swallowing efficiency and swallowing safety [2, 51]. Table 1 provides a summary of key findings and related swallowing interventions applicable during FEES. Based on the individual impairment profile, suitable maneuvers should be applied during FEES and their effects noted in the FEES-report.

Table 1 Swallowing interventions to be tested during FEES depending on the key findings (based on [51, 88])

Advanced assessment

The second part of the integrated FEES-report covers advanced findings and interpretations of the endoscopic swallowing evaluation in four steps (Fig. 2).

Step 6– Special findings

Special findings refer to distinctive features that are usually detected because the examiner has decided to carry out a specific FEES-protocol during or after running the FEES standard protocol. The additional protocols mentioned here, are easily implemented in the endoscopic swallowing evaluation and help answering specific questions that usually come up before or during the investigation [10].

Distraction

To assess the impact of distraction on swallowing performance the FEES-dual task protocol may be applied [52, 53]. In general, swallowing often occurs concurrently with mentally demanding activities, such as watching television or engaging in group conversations [54]. This is not reflected in the standard dysphagia examination, which mainly evaluates volitional swallowing in a more or less artificial examination context. As the simultaneous execution of two tasks (dual-task) often leads to delayed reaction times or deteriorated performances in one or both tasks—especially in patients with neurological disorders—exploring this aspect may be relevant when assessing swallowing in diverse patient groups and clinical settings. During the FEES-dual task paradigm the baseline FEES without interference is compared with a cognitive dual task on the one hand (memorizing a 6-digit number during the swallowing trials and recalling it thereafter) and a motor dual task (alternately using two click-devices with the right and left hand as often as possible during swallowing) on the other hand [53]. For comprehensively assessing swallowing function on a swallow-to-swallow basis the parameters “premature bolus spillage”, “penetration/aspiration” and “residue” are rated separately on established scales, each ranging from 0 (normal) to 4 (most severe). According to the protocol three boluses each of semisolid, liquid and solid food consistencies are evaluated and a cumulative score is generated by adding up the results of the single swallows, ranging from 0 (best) to 108 (worst) [52]. This dual task paradigm has been shown to have sufficient inter- and intra-rater reliability and helped to unmask central compensation of impaired swallowing in a cohort of patients with Parkinson’s disease [52].

Swallowing fatigability

Swallowing fatigability, which is characterized by a decline in swallowing function during the execution of repetitive swallows, is a key feature of myasthenic dysphagia and may, more rarely, be also encountered in patients with amyotrophic lateral sclerosis and other neuromuscular disorders. Muscle fatigue during swallowing typically develops over time and is most likely provoked by solid food, which requires a more effective pharyngeal squeeze than liquid or semisolid consistencies. Due to these facts swallowing fatigability may be missed during the execution of the standard FEES protocol, which typically includes only a limited number of swallows. To account for this the fatigable swallowing test (FST) has been developed [55]. For the FST the patient is given in succession up to 30 small pieces of white bread with a size of approximately 3 cm x 3 cm x 0.5 cm each. The number of successfully swallowed boluses until severe residues (> 50% of bolus size) occur, is used to quantify the severity of swallowing fatigability [55]. The FST has been attributed a reasonable sensitivity and specificity for differentiating myasthenic from non-myasthenic dysphagia [47].

Pharyngeal hypesthesia

Intact pharyngeal sensation is crucial for a physiological swallowing process, and conversely, pharyngeal hypesthesia is a key driver of dysphagia [56]. Pharyngeal hypesthesia can be caused both centrally, for example, by damage to somatosensory cortical areas, and peripherally, for example, by injury of the pharyngeal mucosa. Therefore, during FEES pharyngeal sensation should be carefully evaluated. The most common approach to indirectly assessing sensory function consists in determining the patient’s reaction to airway invasion and pharyngeal residue. Thus, the PAS differentiates between penetration and aspiration with and without subsequent ejection from the airway [17]. Additionally, the BRACS not only evaluates the extent and location of pharyngeal residues but also considers the lack of spontaneous clearing swallows as sign for impaired pharyngeal sensation [23]. A very straightforward method for investigating pharyngeal sensation is the so called “touch-technique”. This approach involves touching specific pharyngeal and laryngeal structures with the tip of the endoscope and score the patient’s reaction to this supraphysiological stimulus, which may consist in the laryngeal adductor reflex, swallowing and coughing [57, 58]. A more refined technique for sensory testing is the air pulse method (FEES with sensory testing, FEESST). Here, an air pulse is applied to the pharyngeal wall or laryngeal structures through an additional channel of the endoscope. The pressure of the air pulse can be varied and thus a threshold value is determined at which the laryngeal adductor reflex is triggered [59, 60]. The clinical relevance of FEESST has been discussed controversially, and conflicting results have been published [57, 61, 62]. The FEES-Laryngeal-Swallow-Response-Test (FEES-LSR-Test) also aims for a quantitative description of pharyngeal hypesthesia but, in comparison to FEESST, makes use of a physiological stimulus. For this test a small tube is positioned transnasally in the upper third of the oropharynx with contact to the lateral pharyngeal wall. Increasing volumes of dyed water are injected through the tube, and the latency of swallowing response is determined endoscopically [63]. This test was validated in healthy subjects and clearly distinguished between the physiological state and experimentally induced pharyngeal anesthesia, in addition inter- and intra-rater reliability were excellent [63]. In further studies pharyngeal hypesthesia as documented by the FEES-LSR-Test was correlated with dysphagia severity both in stroke victims [64] and in community-dwelling older adults [65].

Movement disorders

Dysphagia is a clinical hallmark of many movement disorders such as Parkinson’s disease (PD) and atypical Parkinsonian syndromes [66, 67]. In addition to obvious swallowing difficulties, there are also more subtle indicators of abnormal movement patterns that may provide valuable clues in the diagnostic workup of patients and should be specifically addressed during FEES. Oropharyngeal bradykinesia is a frequent symptom in PD patients and may lead to decreased oral bolus control, prolonged transit times during swallowing, premature bolus spillage, drooling of saliva, delayed laryngeal vestibule closure, or aspiration [68]. Endoscopically, bradykinesia may manifest by increased duration of the white-out. While the average length of white-out in older subjects was reported to be 675 ms, PD patients had a white-out duration of 984 ms, which decreased with increasing intestinally supplied dopaminergic dosage to approximately 700 ms [69, 70]. Oropharyngeal freezing (OPF) is another movement pathology occurring during the swallow, which may be present in around one third of PD patients [71]. OPF shares common characteristics of the well-known freezing of gait, which refers to a sudden und temporarily interruption of motion during gait. As described in detail elsewhere [71], three subtypes of OPF have been described. Oropharyngeal festination means that the tongue base performs quick pumping movements that result in inadequate bolus propulsion. Oropharyngeal trembling refers to an ineffective shaking of the tongue and the pharyngeal constrictors. Finally, oropharyngeal akinesia characterizes a complete interruption of the swallowing process. In this condition, the bolus has reached the trigger zones of the swallowing reflex in the hypopharynx, yet, momentarily, no swallow response is elicited. In contrast to these findings that are typically observed during the swallow, specific laryngeal movement abnormalities during a set of dedicated positioning tasks of laryngeal function are considered characteristic of multiple system atrophy (MSA) [72, 73]. Thus, more than 90% of MSA patients showed an irregular arytenoid cartilage movement (iACM), which is an irregular jitter and flutter of the arytenoid region occurring during breathing and phonation, while iACM were not seen in any of the studied PD patients [73]. Hence, this MSA-protocol should be added to the standard physiological assessment of FEES, if a movement disorder is suspected in the respective patient.

Swallowing medication

Many patients with dysphagia encounter challenges when taking oral medication, particularly swallowing tablets and capsules. Apart from aspiration and associated complications, patients may discontinue their medication or make unsuitable modifications due to these difficulties (e.g., crushing, breaking, and opening of tablets and capsules). The latter may lead to numerous problems, such as decreased accuracy of dose, increased toxicity, reduced stability, and alteration of pharmacokinetics [74]. As per recent guidelines, it is recommended that swallowing of tablets be routinely assessed as part of the swallowing evaluation, particularly for patients with dysphagia who need to take oral medication [10, 12], and the most suitable form of oral administration should be identified. For the classification of medication dysphagia, a dedicated score that specifically evaluates the efficiency and safety of swallowing pills and capsules may be used [75]. This 5-point ordinal score has been attributed a high interrater reliability both for the subscale of swallowing efficiency (κ = 0.89) and swallowing safety (κ = 0.86). With regards to validity this score was significantly linked to the occurrence of motor complications in a cohort of 66 PD patients [75].

Step 7– Phenotypes of swallowing impairment

Based on the salient findings and taking into consideration the results of the advanced assessment of step 6, the phenotype of swallowing impairment should be determined. A phenotypic classification of neurogenic dysphagia that may be used for this purpose was developed by means of a systematic literature review, fine-tuned by an additional analysis of 200 selected FEES videos and validated using more than 1000 additional FEES videos from a variety of different neurological diseases [37]. As a result of this analytical process the following seven phenotypes were derived: (1) premature bolus spillage, (2) delayed swallowing reflex, (3) predominance of residue in the valleculae, (4) predominance of residues in the piriform sinus, (5) pharyngeal movement disorder, (6) fatigable swallowing weakness, and (7) complex phenotye. Some of these phenotypes, such as premature spillage, residue in the valleculae, or the complex pathology occurred in many neurological diseases and can therefore be considered as transdiagnostic patterns in neurogenic dysphagia. Other phenotypes such as residue with predominance in the piriform sinus, impaired swallowing reflex, pharyngolaryngeal movement disorders, and fatigable swallowing weakness may serve as indicators for specific diseases [37]. Based on these findings, Table 2 matches the different phenotypes to diseases that affect the central nervous system or peripheral components of the swallowing network. The interrater agreement of this phenotypic classification of FEES findings was strong (κ = 0.84) [37].

Table 2 Typical FEES-phenotypes in different neurological disorders (modified from [37])

Step 8– Pathomechanism

In this step, FEES findings characterizing the key aspects of the patient’s swallowing impairment need to be scrutinized with regards to the underlying pathophysiology. This point will be particularly important for designing an appropriate treatment plan later (see step 11). First, as summarized in Table 3, findings from the physiological examination should be considered. These non-swallow observations should then be matched with results of the swallow studies. Here, as already stressed by Susan Langmore in her pertinent book and updated in two recent reviews by the same author and Schindler and colleagues respectively [2, 15, 51], most relevant clues are provided by analyzing the distribution of pharyngeal residues. For example, residues at the tongue base or in the valleculae are most often caused by poor tongue base retraction. Residues in the piriform sinus suggest impaired opening of the upper esophageal sphincter, weak pharyngeal contraction and reduced hyolaryngeal elevation. Next, if present, the timing of airway invasion should be looked at. Finally, there are several additional observations during the swallow assessment that help clarifying the individual patient’s pathophysiology. For example, the frequently encountered phenomenon of preswallow pharyngeal spillage may be due to both, an impaired oral bolus control and a delayed swallowing reflex. Apart from that, however, also the less common and more difficult to classify conditions of akinesia of swallowing [71] and palatal myoclonus can be relevant here [76]. Recently, the white-out and its changes from normal have been studied more closely. Thus, as already mentioned above, a prolonged white-out may be due to pharyngeal bradykinesia, a hallmark of PD-related dysphagia [69], and, presumably, may also be seen in pharyngeal dystonia. A weak white-out in turn, which can be classified with a simple ordinal scale [14], is related to a weakened pharyngeal contraction and, possibly, impaired retraction of the tongue-base. The so-called postswallow-stage, which immediately follows the white-out, may also provide clues for deciphering the underlying pathophysiology. According to a recent study analyzing a set of simultaneous VFSS-FEES examinations, incomplete epiglottic inversion was related to a combined effect of reduced tongue-base retraction, impaired hyo-laryngeal elevation and weakened pharyngeal contraction [77].

Table 3 Clinical observations during FEES and related pathophysiology (based on reviews [2, 15, 51], new references added where appropriate)

Step 9– Etiology and differential diagnoses

This step is of particular relevance if the etiology of dysphagia in the patient at hand has not been determined yet. In this case the phenotypic classification (step 7) and pathophyisiological considerations (step 8) may be used to put forward a comprehensive list of possible differential diagnoses [10]. However, even in patients with a known diagnosis typically associated with swallowing impairments, it should be carefully checked, whether the observed dysphagia phenotype is compatible with this diagnosis.

Recommendations

This concluding section of the integrated FEES-report aims to provide precise recommendations for subsequent diagnostic and therapeutic procedures as well as for the timing for a follow-up examination (Fig. 2).

Step 10 - Further diagnostics to elucidate the pathophysiology and/or etiology of dysphagia

This step is optional and only applies if either the etiology or the pathophysiology of dysphagia after FEES is still unclear and needs to be clarified.

Additional dysphagia diagnostics

These include FEES-based medication tests, VFSS and high-resolution manometry (HRM).

FEES-based medication tests evaluate whether a swallowing impairment improves after application of a specific pharmaceutical agent. The FEES-Edrophonium test, which incorporates FEES with simultaneous intravenous application of Edrophonium during a standardized swallowing task, has been designed to uncover myasthenic dysphagia [78]. This test has been shown to be highly reliable [79] and, both, sufficiently sensitive and specific [47]. Due to these robust clinical properties the FEES-Edrophonium test is key part of an algorithm for the diagnostic workup of neurogenic dysphagia of undetermined etiology [80]. The FEES-L-Dopa test evaluates whether dysphagia in patients with parkinsonian syndromes improves after application of a sufficiently high dose of fast-dissolving L-Dopa. For semiquantitative rating of dysphagia severity the same protocol as mentioned in the section dealing with the dual-task paradigm is used. The FEES-L-Dopa test has been shown to be applicable without complications in the clinical routine and was attributed excellent inter- and intra-rater reliability [35, 36].

VFSS is a contrast based, radiological examination of the entire swallowing act including oral, pharyngeal, and esophageal stages. Apart from qualitative parameters VFSS also offers a variety of quantitative measures, such as the oral onset time, the oral transit time, the pharyngeal transit time, the anterior-superior movement of the hyoid, the duration of the velopharyngeal closure and the duration and width of the opening of the upper esophagus sphincter. Based on VFSS it is possible to detect and to comprehensively describe complex pathomechanisms of swallowing disorders affecting laryngo-pharyngeal and -esophageal interactions [10]. Therefore, according to a recent guideline, VFSS should be considered in particular, if based on FEES a complex pathophysiology of the pharyngeal phase, an opening disorder of the upper esophageal sphincter or an impairment of the esophageal phase is suspected [10].

HRM allows the endoluminal pressure conditions in the pharynx and esophagus to be measured during the swallowing act. The method is particularly suitable to prove relaxation disorders of the upper esophageal sphincter, for example after dorsolateral medulla oblongata infarction or in the course of inflammatory myopathies, and motility disorders of the tubular or lower esophagus, such as achalasia and diffuse esophagospasm. For esophageal HRM normal values have been established for the following parameters: resting pressure, duration of upper and lower esophageal sphincter opening as well as peristalsis, pressure and amplitudes of the tubular esophagus. Although there is still a lack of normative data, pharyngeal HRM has been used in different neurological diseases, such as stroke, PD and myopathies to decipher patterns of swallowing impairment [10].

Additional non-swallow diagnostics

If, based on the FEES findings, one specific disorder or a set of differential diagnoses is considered, further (non-swallow) diagnostic steps may be planned to determine the etiology of dysphagia. A summary line-up of diseases and related diagnostics is provided in Table 4. For example, in case of a suspected motoneuron disorder with bulbar onset dedicated electromyography should be scheduled. If oculopharyngeal muscular dystrophy needs to be considered, e.g. due to a positive family history, genetic testing is warranted. In cases where an acute inflammatory polyneuropathy comes into account, lumbar puncture and neurography may be the next diagnostic steps at hand. Finally, as outlined elsewhere in detail, the diagnostic-workup of suspected inflammatory myopathies includes antibody-testing, neurophysiological studies, magnetic resonance imaging of the muscles and a muscle biopsy, among others [80].

Table 4 Neurological diseases featuring dysphagia as possible main symptom, and important additional diagnostics [90]

Step 11– Therapeutic interventions

As summarized in a recent guideline, a variety of different therapeutic methods is now available for the treatment of neurogenic dysphagia [10]. Principally, the indication for a specific treatment is determined by both, the pathophysiology and the etiology of dysphagia, which is why the preceding diagnostic work-up is of key importance.

Therapeutic strategies include on the one hand protective and compensatory interventions, which aim at reducing the risk of dysphagia-related complications without targeting swallowing function itself. This category comprises of dietary interventions, in particular prescription of texture-modified food and thickened liquids, oral hygiene, i.e. consistent oral and dental cleaning, nutritional interventions, such as use of high-caloric oral supplementation or initiation of tube-feeding, and compensatory behavioral swallowing interventions, like the chin-down posture or the head-turn [10]. On the other hand, mainly driven by more recent clinical research, there is an expanding armamentarium of restorative treatment options available, which aim at improving swallowing physiology itself. Apart from restorative behavioral swallowing interventions, for example the Shaker exercise, Chin-tuck-against-resistance or expiratory muscle strength training, different neurostimulation modalities such as transcranial direct current stimulation, pharyngeal electrical stimulation or neuromuscular electrical stimulation need to be mentioned here. In addition, there is a growing body of evidence supporting the use of different pharmacological agents like capsaicinoids, and, finally, in selected patients minimally invasive or surgical procedures come into consideration, in particular balloon-dilatation or myotomy in case of cricopharyngeal dysfunction [10].

Step 12– Follow-up examination

Scheduling the follow-up examination constitutes the final step of the integrated FEES-report. While in some patients no further FEES is necessary, for example at the end of a successful rehabilitation or in cases where the suspicion of dysphagia was not confirmed, many patients will have to be re-evaluated further down the line. The interval to the next swallowing assessment is determined by a variety of factors, such as the nature and the expected course of the disease, the treatment performed and the occurrence of complications. Thus, for example, in acute stroke, dysphagia is often severe at the onset of the disease, necessitating dietary adjustments or even tube feeding, but may improve rapidly within the first two weeks [11]. In such a clinical scenario, a follow-up assessment should be scheduled within the first week, which is also recommended by guidelines [81]. In stroke victims with a more complicated course, serial FEES may be required early on to adequately manage the swallowing impairment and its complications [82]. At the other end of the spectrum, there are patients with neurogenic dysphagia due to slowly progressive neurodegenerative disorders like PD. In a clinically stable situation regular follow-up examinations may take place in longer intervals, for example once a year or once every two years. However, the situation obviously changes if complications like an akinetic crisis occur, or the patient presents with new onset of motor-fluctuations indicating disease progression also typically affecting the swallowing function [68]. Finally, a medium term follow-up should be considered, among others, in chronic but more rapid-progressive neurodegenerative disorders, such ALS [83, 84], diseases with fluctuating clinical features, in particular Myasthenia gravis [47], and after specific interventions with unclear long-term effects, for example dilatation of the cricopharyngeal muscle in patients with myositis [85].

Conclusions

Today, due to the complexity of the condition, patients with neurogenic dysphagia are supposed to be managed by multiprofessional teams [10]. While potential patient-centered benefits are obvious, any team-approach increases the need for targeted, comprehensive and comprehensible communication [86, 87]. The framework for creating an integrated FEES-report presented in this article was designed to foster, clarify and improve interaction in the multiprofessional team. The structured approach systematically moves from salient findings to more advanced domains such as dysphagia severity, phenotypes of swallowing impairment and pathomechanisms. That way, whenever available, validated scales and scores were used to increase the diagnostic yield of the report. Finally, FEES-findings are put into the perspective of the clinical situation at hand, thereby integrating the patient’s clinical situation into the swallowing-specific observations. Here, the potential etiology of dysphagia and conceivable differential diagnoses are considered, further diagnostic steps are proposed, treatment options are evaluated, and a re-assessment is scheduled.

Already by its design this framework is open to continuous evolution. Any new items, for example further FEES-protocols and pathophysiological observations, improved disease-related knowledge and novel treatment options will easily be incorporated. In addition, it is conceivable that this approach may also be customized to report on FEES in structural dysphagia.

Data availability

Not applicable.

Abbreviations

AChR:

Acetylcholin Receptor

AD:

Alzheimer‘s Dementia

ALS:

Amyotrophic Lateral Sclerosis

BRACS:

Boston residue and clearance scale

CIP/CIM:

Critical Illness Polyneuropathy/Myopathy

DISH:

Diffuse idiopathic skeletal hyperostosis

DIGEST:

Dynamic Imaging Grade of Swallowing Toxicity

EMG:

Electromyography

ENG:

Electroneurography

FEES:

Flexible Endoscopic Evaluation of Swallowing

FEES-LSR-Test:

FEES-Laryngeal-Swallow-Response-Test

FEESST:

FEES with Sensory Testing

FOIS:

Functional Oral Intake Scale

FST:

Fatigable Swallowing Test

FTD:

Frontotemporal Dementia

GBS:

Guillain-Barré syndrome

HRM:

High Resolution Manometry

HSP:

Hereditary Spastic Paraparesis

iACM:

irregular Arytenoid Cartilage Movement

LEMS:

Lambert-Eaton Myathenic Syndrome

MRI:

Magnetic Resonance Imaging

MSA:

Multiple System Atrophy

MuSK:

Muscle-specific Tyrosine Kinase

NCS:

Nerve Conduction Study

OPF:

Oropharyngeal freezing

PAS:

Penetration-Aspiration Scale

PD:

Parkinson’s Disease

PNS:

Peripheral Nervous System

PSP:

Progressive Supranuclear Palsy

SBMA:

Spinobulbar muscular atrophy

SLP:

Speech and Language Pathologist

SSRS:

Secretion Severity Rating Scale

UES:

Upper Esophageal Sphincter

VD:

Vascular Dementia

VFSS:

Videofluoroscopic Swallowing Study

YPRSRS:

Yale pharyngeal residue severity rating scale

References

  1. Langmore, S. E., Schatz, K., & Olsen, N. (1988). Fiberoptic endoscopic examination of swallowing safety: A new procedure. Dysphagia, 2, 216–219.

    Article  CAS  PubMed  Google Scholar 

  2. Langmore, S. E. (2017). History of fiberoptic endoscopic evaluation of swallowing for evaluation and management of pharyngeal dysphagia: Changes over the years. Dysphagia, 32(1), 27–38.

    Article  PubMed  Google Scholar 

  3. Dziewas, R., Glahn, J., Helfer, C., Ickenstein, G., Keller, J., Ledl, C., Lindner-Pfleghar, B., D, G. N., Prosiegel, M., Riecker, A., et al. (2016). Flexible endoscopic evaluation of swallowing (FEES) for neurogenic dysphagia: Training curriculum of the German society of Neurology and the German stroke society. BMC Medical Education, 16, 70.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Birchall, O., Bennett, M., Lawson, N., Cotton, S. M., & Vogel, A. P. (2021). Instrumental Swallowing Assessment in adults in residential aged Care homes: A scoping review. Journal of the American Medical Directors Association, 22(2), 372–379e376.

    Article  PubMed  Google Scholar 

  5. Langmore, S. E., Scarborough, D. R., Kelchner, L. N., Swigert, N. B., Murray, J., Reece, S., Cavanagh, T., Harrigan, L. C., Scheel, R., Gosa, M. M. (2022). Tutorial on Clinical Practice for Use of the Fiberoptic Endoscopic Evaluation of Swallowing Procedure With Adult Populations: Part 1. American journal of speech-language pathology / American Speech-Language-Hearing Association 31(1):163–187.

  6. Fibreoptic Endoscopic Evaluation of Swallowing (FEES) The role of speech and language therapy. Royal College of Speech and Language Therapists Position Paper [http://www.rcslt.org/members/publications/publications2/fees_position_paper_300315].

  7. Graf, S., Keilmann, A., Dazert, S., Deitmer, T., Stasche, N., Arnold, B., Löhler, J., Arens, C., & Pflug, C. (2019). [Training curriculum for the Certificate Diagnostics and Therapy of Oropharyngeal Dysphagia, including FEES, of the German Society for Phoniatrics and Pedaudiology and the German Society for Otolaryngology, Head and Neck surgery]. Laryngo- rhino- otologie, 98(10), 695–700.

    PubMed  Google Scholar 

  8. Yoshida, M., Kagaya, H., Kamakura, Y., Miura, Y., Saitoh, E., Okawa, Y., & Sanada, H. (2020). Safety and the effectiveness of a new education program for nurses to assess swallowing function using fiberoptic endoscopic evaluation of swallowing (FEES). Japan Journal of Nursing Science: JJNS, 17(2), e12313.

    Article  PubMed  Google Scholar 

  9. Dziewas, R., Baijens, L., Schindler, A., Verin, E., Michou, E., & Clave, P. (2017). European Society for Swallowing Disorders FEES Accreditation Program for Neurogenic and Geriatric Oropharyngeal Dysphagia. Dysphagia, 32(6), 725–733.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Dziewas, R., Allescher, H. D., Aroyo, I., Bartolome, G., Beilenhoff, U., Bohlender, J., Breitbach-Snowdon, H., Fheodoroff, K., Glahn, J., Heppner, H. J., et al. (2021). Diagnosis and treatment of neurogenic dysphagia - S1 guideline of the German society of Neurology. Neurol Res Pract, 3(1), 23.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Labeit, B., Michou, E., Hamdy, S., Trapl-Grundschober, M., Suntrup-Krueger, S., Muhle, P., Bath, P. M., & Dziewas, R. (2023). The assessment of dysphagia after stroke: State of the art and future directions. The Lancet Neurology, 22(9), 858–870.

    Article  PubMed  Google Scholar 

  12. Dziewas, R., Michou, E., Trapl-Grundschober, M., Lal, A., Arsava, E. M., Bath, P. M., Clavé, P., Glahn, J., Hamdy, S., Pownall, S., et al. (2021). European Stroke Organisation and European Society for Swallowing Disorders guideline for the diagnosis and treatment of post-stroke dysphagia. Eur Stroke J, 6(3), Lxxxix–cxv.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Pflug, C., Bihler, M., Emich, K., Niessen, A., Nienstedt, J. C., Flugel, T., Koseki, J. C., Plaetke, R., Hidding, U., Gerloff, C., et al. (2018). Critical Dysphagia is common in Parkinson Disease and occurs even in early stages: A prospective cohort study. Dysphagia, 33(1), 41–50.

    Article  PubMed  Google Scholar 

  14. Labeit, B., Perlova, K., Pawlitzki, M., Ruck, T., Muhle, P., Claus, I., Suntrup-Krueger, S., Wiendl, H., Dziewas, R., & Warnecke, T. (2021). Predictors, outcome and characteristics of oropharyngeal dysphagia in idiopathic inflammatory myopathy. Muscle & nerve.

  15. Langmore, S. E. (2001). Scoring a FEES examination. In: Endoscopic evaluation and treatment of swallowing disorders edn. Edited by Langmore SE. New York, Stuttgart: Thieme;: 101–143.

  16. Warnecke, T., Dziewas, R., & Langmore, S. (2021). Neurogenic dysphagia.

  17. Rosenbek, J. C., Robbins, J., Roecker, E. B., Coyle, J. L., & Wood, J. L. (1996). A penetration-aspiration scale. Dysphagia, 11, 93–98.

    Article  CAS  PubMed  Google Scholar 

  18. Murray, J., Langmore, S. E., Ginsberg, S., & Dostie, A. (1996). The significance of accumulated oropharyngeal secretions and swallowing frequency in predicting aspiration. Dysphagia, 11, 99–103.

    Article  CAS  PubMed  Google Scholar 

  19. Colodny, N. (2002). Interjudge and intrajudge reliabilitie in fiberoptic endoscopic evaluation of swallowing (FEES) using the penetration-aspiration scale: A replication study. Dysphagia, 17, 308–315.

    Article  PubMed  Google Scholar 

  20. Butler, S. G., Markley, L., Sanders, B., & Stuart, A. (2015). Reliability of the penetration aspiration scale with flexible endoscopic evaluation of swallowing. The Annals of Otology Rhinology and Laryngology, 124(6), 480–483.

    Article  PubMed  Google Scholar 

  21. Pluschinski, P., Zaretsky, E., Stöver, T., Murray, J., Sader, R., & Hey, C. (2016). Validation of the secretion severity rating scale. European Archives of oto-rhino-laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 273(10), 3215–3218.

    PubMed  Google Scholar 

  22. Neubauer, P. D., Rademaker, A. W., & Leder, S. B. (2015). The Yale Pharyngeal Residue Severity rating scale: An anatomically defined and image-based Tool. Dysphagia, 30(5), 521–528.

    Article  PubMed  Google Scholar 

  23. Kaneoka, A. S., Langmore, S. E., Krisciunas, G. P., Field, K., Scheel, R., McNally, E., Walsh, M. J., O’Dea, M. B., & Cabral, H. (2013). The Boston Residue and Clearance Scale: Preliminary reliability and validity testing. Folia Phoniatrica et logopaedica: Official Organ of the International Association of Logopedics and Phoniatrics (IALP), 65(6), 312–317.

    Article  PubMed  Google Scholar 

  24. Atar, Y., Atar, S., Ilgin, C., Anarat, M. E. A., Uygan, U., & Uyar, Y. (2022). Validity and reliability of the Turkish translation of the Yale Pharyngeal Residue Severity rating scale. Dysphagia, 37(3), 655–663.

    Article  PubMed  Google Scholar 

  25. Gerschke, M., Schottker-Koniger, T., Forster, A., Netzebandt, J. F., & Beushausen, U. M. (2018). Validation of the German Version of the Yale Pharyngeal Residue Severity Rating Scale. Dysphagia.

  26. Nordio, S., Maistrello, L., D’Imperio, D., Favaretto, N., Dellai, A., Montino, S., Agostinelli, A., Ramacciotti, G., Gheller, F., Berta, G., et al. (2023). Validity and reliability of the Italian translation of the Yale Pharyngeal Residue Severity rating scale. Acta Otorhinolaryngologica Italica: Organo Ufficiale Della Societa Italiana Di Otorinolaringologia e Chirurgia cervico-facciale, 43(1), 12–19.

    Article  PubMed  Google Scholar 

  27. Rocca, S., Pizzorni, N., Valenza, N., Negri, L., & Schindler, A. (2022). Reliability and Construct Validity of the Yale Pharyngeal Residue Severity rating scale: Performance on videos and effect of Bolus consistency. Diagnostics (Basel Switzerland) 12(8).

  28. Souza, G. A. D., Silva, R. G. D., Cola, P. C., & Onofri, S. M. M. (2019). Pharyngeal residue in neurogenic oropharyngeal dysphagia. CoDAS, 31(6), e20180160.

    Article  PubMed  Google Scholar 

  29. Yoon, J. A., Kim, S. H., Jang, M. H., Kim, S. D., & Shin, Y. B. (2019). Correlations between Aspiration and pharyngeal Residue Scale scores for fiberoptic endoscopic evaluation and Videofluoroscopy. Yonsei Medical Journal, 60(12), 1181–1186.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Francesco, M., Nicole, P., Letizia, S., Claudia, B., Daniela, G., & Antonio, S. (2022). Mixed consistencies in Dysphagic patients: A myth to dispel. Dysphagia, 37(1), 116–124.

    Article  PubMed  Google Scholar 

  31. Shapira-Galitz, Y., Levy, A., Madgar, O., Shpunt, D., Zhang, Y., Wang, B., Wolf, M., & Drendel, M. (2021). Effects of carbonation of liquids on penetration-aspiration and residue management. European Archives of oto-rhino-laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 278(12), 4871–4881.

    PubMed  Google Scholar 

  32. Labeit, B., Ahring, S., Boehmer, M., Sporns, P., Sauer, S., Claus, I., Roderigo, M., Suntrup-Krueger, S., Dziewas, R., Warnecke, T., et al. (2022). Comparison of simultaneous swallowing Endoscopy and Videofluoroscopy in Neurogenic Dysphagia. Journal of the American Medical Directors Association, 23(8), 1360–1366.

    Article  PubMed  Google Scholar 

  33. Hunting, A., Steffanoni, B., Jacques, A., & Miles, A. (2023). Accumulated secretions and Associated Aerodigestive function in patients with Dysphagia. American Journal of speech-language Pathology / American Speech-Language-Hearing Association, 32(6), 2691–2702.

    Article  Google Scholar 

  34. Ardenghi, L. G., Signorini, A. V., Maahs, G. S., Selaimen, F., Deutsch, K. M., Dornelles, S., & Rieder, C. R. M. (2021). Deglutition Impairment during Dual Task in Parkinson Disease is Associated with Cognitive Status. International Archives of Otorhinolaryngology, 25(1), e41–e47.

    Article  PubMed  Google Scholar 

  35. Warnecke, T., Suttrup, I., Schroder, J. B., Osada, N., Oelenberg, S., Hamacher, C., Suntrup, S., & Dziewas, R. (2016). Levodopa responsiveness of dysphagia in advanced Parkinson’s disease and reliability testing of the FEES-Levodopa-test. Parkinsonism & Related Disorders, 28, 100–106.

    Article  Google Scholar 

  36. Warnecke, T., Oelenberg, S., Teismann, I., Hamacher, C., Lohmann, H., Ringelstein, E. B., & Dziewas, R. (2010). Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy. Movement Disorders: Official Journal of the Movement Disorder Society, 25, 1239–1245.

    Article  PubMed  Google Scholar 

  37. Warnecke, T., Labeit, B., Schroeder, J., Reckels, A., Ahring, S., Lapa, S., Claus, I., Muhle, P., Suntrup-Krueger, S., & Dziewas, R. (2021). Neurogenic dysphagia: Systematic review and proposal of a classification system. Neurology, 96(6), e876–e889.

    Article  CAS  PubMed  Google Scholar 

  38. Robison, R., DiBiase, L., Ashley, A., McElheny, K., Anderson, A., Wymer, J. P., & Plowman, E. K. (2022). Swallowing Safety and Efficiency Impairment profiles in individuals with amyotrophic lateral sclerosis. Dysphagia, 37(3), 644–654.

    Article  PubMed  Google Scholar 

  39. Dejaeger, E., Pelemans, W., Ponette, E., & Joosten, E. (1997). Mechanisms involved in postdeglutition retention in the elderly. Dysphagia, 12(2), 63–67.

    Article  CAS  PubMed  Google Scholar 

  40. Hutcheson, K. A., Barrow, M. P., Barringer, D. A., Knott, J. K., Lin, H. Y., Weber, R. S., Fuller, C. D., Lai, S. Y., Alvarez, C. P., Raut, J., et al. (2017). Dynamic imaging Grade of swallowing toxicity (DIGEST): Scale development and validation. Cancer, 123(1), 62–70.

    Article  PubMed  Google Scholar 

  41. Hutcheson, K. A., Barbon, C. E. A., Alvarez, C. P., & Warneke, C. L. (2022). Refining measurement of swallowing safety in the dynamic imaging Grade of swallowing toxicity (DIGEST) criteria: Validation of DIGEST version 2. Cancer, 128(7), 1458–1466.

    Article  CAS  PubMed  Google Scholar 

  42. Starmer, H. M., Arrese, L., Langmore, S., Ma, Y., Murray, J., Patterson, J., Pisegna, J., Roe, J., Tabor-Gray, L., & Hutcheson, K. (2021). Adaptation and validation of the dynamic imaging Grade of swallowing toxicity for flexible endoscopic evaluation of swallowing: DIGEST-FEES. Journal of Speech Language and Hearing Research: JSLHR, 64(6), 1802–1810.

    Article  PubMed  Google Scholar 

  43. Simon, S. R., Wieland, M. W. M., Hendriks, C., Pilz, W., Schindler, A., Winkens, B., & Baijens, L. W. J. (2023). Intra and interobserver agreement of the Dynamic Imaging Grade of Swallowing Toxicity Scale (DIGEST) in fiberoptic endoscopic evaluation of swallowing (FEES): the importance of observer-tailored training. European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 280(6):2865–2876.

  44. Chandrashekaraiah, B. (2023). Impact of Effortful swallow with Progressive Resistance on Swallow Safety, Efficiency and Quality of Life in individuals with Post-stroke Dysphagia: Analysis using DIGEST- FEES and SWAL-QOL. Indian Journal of Otolaryngology and head and neck Surgery: Official Publication of the Association of Otolaryngologists of India, 75(4), 2836–2841.

    Article  PubMed  Google Scholar 

  45. Labeit, B., Lapa, S., Muhle, P., Suntrup-Krueger, S., Claus, I., Gandor, F., Ahring, S., Oelenberg, S., Dziewas, R., & Warnecke, T. (2023). Validation of the DIGEST-FEES as a Global Outcome Measure for Pharyngeal Dysphagia in Parkinson’s Disease. Dysphagia.

  46. Lapa, S., Claus, I., Reitz, S. C., Quick-Weller, J., Sauer, S., Colbow, S., Nasari, C., Dziewas, R., Kang, J. S., Baudrexel, S., et al. (2020). Effect of thalamic deep brain stimulation on swallowing in patients with essential tremor. Annals of Clinical and Translational Neurology, 7(7), 1174–1180.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Warnecke, T., Im, S., Labeit, B., Zwolinskaya, O., Suntrup-Krüger, S., Oelenberg, S., Ahring, S., Schilling, M., Meuth, S., Melzer, N., et al. (2021). Detecting myasthenia gravis as a cause of unclear dysphagia with an endoscopic tensilon test. Therapeutic Advances in Neurological Disorders, 14, 17562864211035544.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Schroder, J. B., Marian, T., Muhle, P., Claus, I., Thomas, C., Ruck, T., Wiendl, H., Warnecke, T., Suntrup-Krueger, S., Meuth, S., et al. (2019). Intubation, tracheostomy, and decannulation in patients with Guillain-Barre-syndrome-does dysphagia matter? Muscle & Nerve, 59(2), 194–200.

    Article  Google Scholar 

  49. Dziewas, R., auf dem Brinke, M., Birkmann, U., Bräuer, G., Busch, K., Cerra, F., Damm-Lunau, R., Dunkel, J., Fellgiebel, A., Garms, E., et al. (2019). Safety and clinical impact of FEES– results of the FEES-Registry. Neurological Practice and Research, 1(1), 1–8.

    Article  Google Scholar 

  50. Dziewas, R., Warnecke, T., Oelenberg, S., Teismann, I., Zimmermann, J., Kraemer, C., Ritter, M., Ringelstein, E. B., & Schabitz, W. R. (2008). Towards a basic endoscopic assessment of swallowing in acute stroke - development and evaluation of a simple dysphagia score. Cerebrovascular Diseases (Basel Switzerland), 26, 41–47.

    Article  PubMed  Google Scholar 

  51. Schindler, A., Baijens, L. W. J., Geneid, A., & Pizzorni, N. (2022). Phoniatricians and otorhinolaryngologists approaching oropharyngeal dysphagia: An update on FEES. European Archives of oto-rhino-laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 279(6), 2727–2742.

    PubMed  Google Scholar 

  52. Labeit, B., Claus, I., Muhle, P., Regner, L., Suntrup-Krueger, S., Dziewas, R., & Warnecke, T. (2021). Effect of cognitive and motor dual-task on oropharyngeal swallowing in Parkinson’s disease. European Journal of Neurology, 28(3), 754–762.

    Article  PubMed  Google Scholar 

  53. Muhle, P., Claus, I., Labeit, B., Ogawa, M., Dziewas, R., Suntrup-Krueger, S., & Warnecke, T. (2020). Effects of cognitive and motor dual-tasks on oropharyngeal swallowing assessed with FEES in healthy individuals. Scientific Reports, 10(1), 20403.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Herman, C. P. (2015). The social facilitation of eating. A review. Appetite, 86, 61–73.

    Article  PubMed  Google Scholar 

  55. Dziewas, R., Warnecke, T., Ritter, M., Dittrich, R., Schilling, M., Schabitz, W. R., Ringelstein, E. B., & Nabavi, D. G. (2006). Fatigable swallowing in myasthenia gravis - proposal of a standardized test and report of a case. J Clin Neuromusc Dis, 8, 12–15.

    Article  Google Scholar 

  56. Steele, C. M., & Miller, A. J. (2010). Sensory input pathways and mechanisms in swallowing: A review. Dysphagia, 25(4), 323–333.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Kaneoka, A., Krisciunas, G. P., Walsh, K., Raade, A. S., & Langmore, S. E. (2015). A comparison of 2 methods of endoscopic laryngeal sensory testing: A preliminary study. The Annals of Otology Rhinology and Laryngology, 124(3), 187–193.

    Article  PubMed  Google Scholar 

  58. Marian, T., Schroder, J. B., Muhle, P., Claus, I., Riecker, A., Warnecke, T., Suntrup-Krueger, S., & Dziewas, R. (2017). Pharyngolaryngeal sensory deficits in patients with Middle cerebral artery infarction: Lateralization and relation to overall Dysphagia Severity. Cerebrovascular Diseases Extra, 7(3), 130–139.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Aviv, J. E., Martin, J. H., Keen, M. S., Debell, M., & Blitzer, A. (1993). Air pulse quantification of supraglottic and pharyngeal sensation: A new technique. The Annals of Otology Rhinology and Laryngology, 102, 777–780.

    Article  CAS  PubMed  Google Scholar 

  60. Aviv, J. E., Kim, T., Sacco, R. L., Kaplan, S., Goodhart, K., Diamond, B., & Close, L. G. (1998). FEESST: A new bedside endoscopic test of the motor and sensory components of swallowing. The Annals of Otology Rhinology and Laryngology, 107(5 Pt 1), 378–387.

    CAS  PubMed  Google Scholar 

  61. Aviv, J. E., Spitzer, J., Cohen, M., Ma, G., Belafsky, P., & Close, L. G. (2002). Laryngeal adductor reflex and pharyngeal squeeze as predictors of laryngeal penetration and aspiration. The Laryngoscope, 112, 338–341.

    Article  PubMed  Google Scholar 

  62. Ku, P. K., Vlantis, A. C., Leung, S. F., Lee, K. Y., Cheung, D. M., Abdullah, V. J., van Hasselt, A., & Tong, M. C. (2010). Laryngopharyngeal sensory deficits and impaired pharyngeal motor function predict aspiration in patients irradiated for nasopharyngeal carcinoma. The Laryngoscope, 120(2), 223–228.

    Article  PubMed  Google Scholar 

  63. Labeit, B., Muhle, P., Ogawa, M., Claus, I., Marian, T., Suntrup-Krueger, S., Warnecke, T., Schroeder, J. B., & Dziewas, R. (2019). FEES-based assessment of pharyngeal hypesthesia-proposal and validation of a new test procedure. Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society:e13690.

  64. Labeit, B., Jung, A., Ahring, S., Oelenberg, S., Muhle, P., Roderigo, M., Wenninger, F., von Itter, J., Claus, I., Warnecke, T., et al. (2023). Relationship between post-stroke dysphagia and pharyngeal sensory impairment. Neurol Res Pract, 5(1), 7.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Labeit, B., Muhle, P., von Itter, J., Slavik, J., Wollbrink, A., Sporns, P., Rusche, T., Ruck, T., Hüsing-Kabar, A., Gellner, R., et al. (2022). Clinical determinants and neural correlates of presbyphagia in community-dwelling older adults. Frontiers in Aging Neuroscience, 14, 912691.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Suttrup, I., & Warnecke, T. (2016). Dysphagia in Parkinson’s Disease. Dysphagia, 31(1), 24–32.

    Article  PubMed  Google Scholar 

  67. Calandra-Buonaura, G., Alfonsi, E., Vignatelli, L., Benarroch, E. E., Giannini, G., Iranzo, A., Low, P. A., Martinelli, P., Provini, F., Quinn, N., et al. (2021). Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatment. Parkinsonism & Related Disorders, 86, 124–132.

    Article  CAS  Google Scholar 

  68. Warnecke, T., Schäfer, K. H., Claus, I., Del Tredici, K., & Jost, W. H. (2022). Gastrointestinal involvement in Parkinson’s disease: Pathophysiology, diagnosis, and management. NPJ Parkinson’s Disease, 8(1), 31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Labeit, B., Claus, I., Muhle, P., Suntrup-Krueger, S., Dziewas, R., & Warnecke, T. (2020). Effect of Intestinal Levodopa-Carbidopa Infusion on Pharyngeal Dysphagia: Results from a Retrospective Pilot Study in Patients with Parkinson’s Disease. Parkinson’s disease 2020:4260501.

  70. Mozzanica, F., Lorusso, R., Robotti, C., Zambon, T., Corti, P., Pizzorni, N., Vanderwegen, J., & Schindler, A. (2019). Effect of Age, Sex, Bolus volume, and Bolus consistency on Whiteout Duration in healthy subjects during FEES. Dysphagia, 34(2), 192–200.

    Article  PubMed  Google Scholar 

  71. Labeit, B., Claus, I., Muhle, P., Lapa, S., Suntrup-Krueger, S., Dziewas, R., Osada, N., & Warnecke, T. (2020). Oropharyngeal freezing and its relation to dysphagia - an analogy to freezing of gait. Parkinsonism & Related Disorders, 75, 1–6.

    Article  Google Scholar 

  72. Warnecke, T., Vogel, A., Ahring, S., Gruber, D., Heinze, H. J., Dziewas, R., Ebersbach, G., & Gandor, F. (2019). The shaking Palsy of the larynx-potential biomarker for multiple system atrophy: A Pilot Study and Literature Review. Frontiers in Neurology, 10, 241.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Gandor, F., Vogel, A., Claus, I., Ahring, S., Gruber, D., Heinze, H. J., Dziewas, R., Ebersbach, G., & Warnecke, T. (2020). Laryngeal Movement disorders in multiple system atrophy: A diagnostic biomarker? Movement Disorders: Official Journal of the Movement Disorder Society, 35(12), 2174–2183.

    Article  PubMed  Google Scholar 

  74. Masilamoney, M., & Dowse, R. (2018). Knowledge and practice of healthcare professionals relating to oral medicine use in swallowing-impaired patients: A scoping review. The International Journal of Pharmacy Practice, 26(3), 199–209.

    Article  PubMed  Google Scholar 

  75. Labeit, B., Berkovich, E., Claus, I., Roderigo, M., Schwake, A. L., Izgelov, D., Mimrod, D., Ahring, S., Oelenberg, S., Muhle, P., et al. (2022). Dysphagia for medication in Parkinson’s disease. NPJ Parkinson’s Disease, 8(1), 156.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Lee, S., Moon, H. I., & Shin, J. H. (2021). Post-stroke palatal tremor as a clinical predictor of dysphagia and its neuroanatomical correlates in patients with midbrain and pontine lesions. Journal of Neural Transmission (Vienna Austria: 1996), 128(12), 1863–1872.

    Article  PubMed  Google Scholar 

  77. Jijakli, A., Borders, J. C., Gottlieb, A., Ramirez, E., Leonard, R., Langmore, S. E., Murray, J., & Pisegna, J. M. (2023). Absent epiglottic inversion as seen on flexible endoscopic evaluations of swallowing (FEES) is associated with a gestalt reduction in swallowing mechanics. American Journal of Otolaryngology, 44(2), 103757.

    Article  PubMed  Google Scholar 

  78. Warnecke, T., Teismann, I., Zimmermann, J., Oelenberg, S., Ringelstein, E. B., & Dziewas, R. (2008). Fiberoptic endoscopic evaluation of swallowing with simultaneous Tensilon application in diagnosis and therapy of myasthenia gravis. Journal of Neurology, 255(2), 224–230.

    Article  PubMed  Google Scholar 

  79. Im, S., Suntrup-Krueger, S., Colbow, S., Sauer, S., Claus, I., Meuth, S. G., Dziewas, R., & Warnecke, T. (2018). Reliability and main findings of the flexible endoscopic evaluation of swallowing-tensilon test in patients with myasthenia gravis and dysphagia. European Journal of Neurology, 25(10), 1235–1242.

    Article  CAS  PubMed  Google Scholar 

  80. Labeit, B., Grond, T., Beule, A. G., Boehmer, M., Thomas, C., Muhle, P., Claus, I., Roderigo, M., Rudack, C., Wiendl, H., et al. (2022). Detecting myositis as a cause of unexplained dysphagia: Proposal for a diagnostic algorithm. European Journal of Neurology, 29(4), 1165–1173.

    Article  PubMed  Google Scholar 

  81. Burgos, R., Breton, I., Cereda, E., Desport, J. C., Dziewas, R., Genton, L., Gomes, F., Jesus, P., Leischker, A., Muscaritoli, M., et al. (2018). ESPEN guideline clinical nutrition in neurology. Clinical Nutrition (Edinburgh Scotland), 37(1), 354–396.

    Article  PubMed  Google Scholar 

  82. Warnecke, T., Dziewas, R., Oelenberg, S., Ritter, M., Dittrich, R., Schäbitz, W. R., Ringelstein, E. B., & Nabavi, D. G. (2006). Serial fiberoptic examination of swallowing in patients with acute stroke and dysphagia: Case report and general considerations. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association, 15, 172–175.

    Article  PubMed  Google Scholar 

  83. Leder, S. B., Novella, S., & Patwa, H. (2004). Use of fiberoptic endoscopic evaluation of swallowing (FEES) in patients with amyotrophic lateral sclerosis. Dysphagia, 19(3), 177–181.

    Article  PubMed  Google Scholar 

  84. Leder, S. B. (1998). Serial fiberoptic endoscopic swallowing evaluations in the management of patients with dysphagia. Archives of Physical Medicine and Rehabilitation, 79, 1264–1269.

    Article  CAS  PubMed  Google Scholar 

  85. Ambrocio, K. R., Garand, K. L. F., Roy, B., Bhutada, A. M., & Malandraki, G. A. (2023). Diagnosing and managing dysphagia in inclusion body myositis: A systematic review. Rheumatology (Oxford England), 62(10), 3227–3244.

    Article  PubMed  Google Scholar 

  86. McGinnis, C. M., Homan, K., Solomon, M., Taylor, J., Staebell, K., Erger, D., & Raut, N. (2019). Dysphagia: Interprofessional Management, Impact, and patient-centered care. Nutrition in Clinical Practice: Official Publication of the American Society for Parenteral and Enteral Nutrition, 34(1), 80–95.

    Article  PubMed  Google Scholar 

  87. Reeves, S., Perrier, L., Goldman, J., Freeth, D., & Zwarenstein, M. (2013). Interprofessional education: Effects on professional practice and healthcare outcomes (update). The Cochrane Database of Systematic Reviews, 2013(3), Cd002213.

    PubMed  PubMed Central  Google Scholar 

  88. Johnson, D. N., Herring, H. J., & Daniels, S. K. (2014). Dysphagia management in stroke rehabilitation. Current Physical Medicine and Rehabilitation Reports, 2, 207–218.

    Article  Google Scholar 

  89. Suttrup, I., Suntrup, S., Oelenberg, S., Hamacher, C., Dziewas, R., & Warnecke, T. (2014). Usefulness of FEES and responsiveness to tetrabenazine in a case of blepharospasm associated with dystonic-tremorous dsyphagia. Parkinsonism & Related Disorders, 20(4), 466–467.

    Article  Google Scholar 

  90. Warnecke, T., Dziewas, R., & Langmore, S. (2021). Special Findings in Neurogenic Dysphagia. In: Neurogenic Dysphagia edn. Edited by Warnecke T, Dziewas R, Langmore S;: 109–222.

Download references

Acknowledgements

Not applicable.

Funding

Open Access funding enabled and organized by Projekt DEAL. SSK is supported by the Else Kröner-Fresenius-Stiftung with an endowed professorship. No funding was received for this review.

Open Access funding enabled and organized by Projekt DEAL.

Author information

Authors and Affiliations

Authors

Contributions

RD conceptualized the manuscript, searched the literature, and wrote the first draft of the manuscript. TW and SSK conceptualized, reviewed and edited the manuscript. BL reviewed the manuscript. PM reviewed the manuscript. IC reviewed the manuscript. SO reviewed the manuscript. SA reviewed the manuscript. CW reviewed the manuscript. AJ reviewed the manuscript. JI reviewed the manuscript. All authors have read and approved the final version of the manuscript.

Corresponding author

Correspondence to Rainer Dziewas.

Ethics declarations

Ethics approval and consent to participate

Not applicable. This review article dd.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dziewas, R., Warnecke, T., Labeit, B. et al. Systematic approach to contextualize findings of flexible endoscopic evaluation of swallowing in neurogenic dysphagia– towards an integrated FEES report. Neurol. Res. Pract. 6, 26 (2024). https://doi.org/10.1186/s42466-024-00321-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s42466-024-00321-8

Keywords